{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:44:54Z","timestamp":1794915894126,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515011167"],"award-info":[{"award-number":["2024A1515011167"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870637"],"award-info":[{"award-number":["81870637"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371418"],"award-info":[{"award-number":["32371418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301172"],"award-info":[{"award-number":["82301172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajo.2025.05.013","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:04:36Z","timestamp":1747422276000},"page":"139-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anti-Acetylcholine Receptor Antibodies in Tear for the Diagnosis of Ocular Myasthenia Gravis"],"prefix":"10.1016","volume":"277","author":[{"given":"CHENG","family":"LU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUANTING","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-9637","authenticated-orcid":false,"given":"YUYING","family":"DONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5639-6476","authenticated-orcid":false,"given":"TING","family":"TANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIAN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YINGWEI","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHENG","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5234-6383","authenticated-orcid":false,"given":"QING","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2025.05.013_bib0001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"26","key":"10.1016\/j.ajo.2025.05.013_bib0002","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"issue":"Pt 7","key":"10.1016\/j.ajo.2025.05.013_bib0003","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ajo.2025.05.013_bib0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle & Nerve"},{"issue":"10","key":"10.1016\/j.ajo.2025.05.013_bib0005","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jamaneurol.2015.1444","article-title":"Clinical utility of acetylcholine receptor antibody testing in ocular myasthenia gravis","volume":"72","author":"Peeler","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ajo.2025.05.013_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120084","article-title":"Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis","volume":"432","author":"Mirian","year":"2022","journal-title":"J Neurol Sci"},{"issue":"14","key":"10.1016\/j.ajo.2025.05.013_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12144781","article-title":"Detection of antibodies against the acetylcholine receptor in patients with Myasthenia Gravis: a comparison of two enzyme immunoassays and a fixed cell-based assay","volume":"12","author":"Gambino","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ajo.2025.05.013_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.nmd.2023.01.002","article-title":"Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis","volume":"33","author":"Hoffmann","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10.1016\/j.ajo.2025.05.013_bib0009","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.clinph.2016.09.012","article-title":"Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis","volume":"127","author":"Liik","year":"2016","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.013_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ncl.2016.08.008","article-title":"Update on ocular myasthenia gravis","volume":"35","author":"Smith","year":"2017","journal-title":"Neurol Clin"},{"issue":"5","key":"10.1016\/j.ajo.2025.05.013_bib0011","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00127893-200109000-00004","article-title":"Tensilon and the diagnosis of myasthenia gravis: are we using the Tensilon test too much?","volume":"7","author":"Okun","year":"2001","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.013_bib0012","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1038\/s41598-024-57825-1","article-title":"Patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital conversations","volume":"14","author":"Anderson","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.05.013_bib0013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jtos.2024.03.011","article-title":"Comparative analysis of human tear fluid and aqueous humor proteomes","volume":"33","author":"Beisel","year":"2024","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.013_bib0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13167-016-0065-3","article-title":"Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine","volume":"7","author":"Hagan","year":"2016","journal-title":"The EPMA journal"},{"key":"10.1016\/j.ajo.2025.05.013_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jtos.2024.06.005","article-title":"Analysis of the heterogeneity and complexity of murine extraorbital lacrimal gland via single-cell RNA sequencing","volume":"34","author":"Huang","year":"2024","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.013_bib0016","first-page":"138","article-title":"Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells","volume":"41","author":"Saitoh-Inagawa","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.013_bib0017","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0161-6420(88)33228-8","article-title":"The immunoarchitecture of the normal human lacrimal gland. Relevancy for understanding pathologic conditions","volume":"95","author":"Wieczorek","year":"1988","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.013_bib0018","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13167-021-00265-y","article-title":"Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine","volume":"12","author":"Zhan","year":"2021","journal-title":"The EPMA journal"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.013_bib0019","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bjo.2003.028340","article-title":"Anti-ro\/SSA and anti-La\/SSB autoantibodies in the tear fluid of patients with Sj\u00f6gren's syndrome","volume":"88","author":"Toker","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.013_bib0020","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3389\/fimmu.2019.01110","article-title":"Investigation of oligoclonal IgG bands in tear fluid of multiple sclerosis patients","volume":"10","author":"H\u00fcmmert","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ajo.2025.05.013_bib0021","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ICU.0000000000000526","article-title":"Ocular myasthenia gravis: an update on diagnosis and treatment","volume":"29","author":"Fortin","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.013_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.814857","article-title":"The role of B1 cells in systemic Lupus Erythematosus","volume":"13","author":"She","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajo.2025.05.013_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104408","article-title":"Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses","volume":"148","author":"Morris","year":"2019","journal-title":"Pharmacol Res"},{"issue":"6717","key":"10.1016\/j.ajo.2025.05.013_bib0024","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/16933","article-title":"Secondary V(D)J recombination in B-1 cells","volume":"397","author":"Qin","year":"1999","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.013_bib0025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2005.040840","article-title":"Analysis of RAG expression by peripheral blood CD5+ and CD5- B cells of patients with childhood systemic lupus erythematosus","volume":"65","author":"Morbach","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.013_bib0026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/nyas.12607","article-title":"Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model","volume":"1362","author":"Xu","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajo.2025.05.013_bib0027","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fimmu.2016.00138","article-title":"An overview of B-1 cells as antigen-presenting cells","volume":"7","author":"Popi","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajo.2025.05.013_bib0028","article-title":"Recent advances in the study of tear biomarkers and contact lens-based biosensors","author":"Bai","year":"2024","journal-title":"Chemical Engineering Journal"},{"key":"10.1016\/j.ajo.2025.05.013_bib0029","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in Myasthenia Gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ajo.2025.05.013_bib0030","first-page":"289","article-title":"Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis","volume":"59","author":"Aurangzeb","year":"2009","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.013_bib0031","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mus.23944","article-title":"Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?","volume":"49","author":"Sanders","year":"2014","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1016\/j.ajo.2025.05.013_bib0032","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0033583513000061","article-title":"Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: insights from Torpedo postsynaptic membranes","volume":"46","author":"Unwin","year":"2013","journal-title":"Q Rev Biophys"},{"issue":"44","key":"10.1016\/j.ajo.2025.05.013_bib0033","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1523\/JNEUROSCI.2833-09.2009","article-title":"Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity","volume":"29","author":"Luo","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajo.2025.05.013_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.666046","article-title":"A stable cell line expressing clustered AChR: a novel cell-based assay for anti-AChR antibody detection in Myasthenia Gravis","volume":"12","author":"Cai","year":"2021","journal-title":"Front Immunol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425002454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425002454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:18:43Z","timestamp":1754918323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425002454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S0002939425002454"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.05.013","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Acetylcholine Receptor Antibodies in Tear for the Diagnosis of Ocular Myasthenia Gravis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}